Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH)
In conclusion, NDGA exerts anti-NASH/anti-fibrotic actions and raises the therapeutic potential of NDGA for treatment of NASH patients with fibrosis and other associated complications.
Source: Molecular and Cellular Endocrinology - Category: Endocrinology Source Type: research
More News: Alcoholism | Cholesterol | Diets | Eating Disorders & Weight Management | Endocrinology | Genetics | Insulin | Liver | Metabolic Syndrome | Nutrition | Obesity | Study | Urology & Nephrology